A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder ; volume:23 ; number:4 ; day:8 ; month:11 ; year:2023 ; pages:339-362 ; date:12.2023
Drugs in R & D ; 23, Heft 4 (8.11.2023), 339-362, 12.2023
- Urheber
-
Miller, James C.
Brooks, Michael A.
Wurzel, Kelly E.
Cox, Emily J.
Wurzel, John F.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-023-00443-5
- URN
-
urn:nbn:de:101:1-2024021310490965476678
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Miller, James C.
- Brooks, Michael A.
- Wurzel, Kelly E.
- Cox, Emily J.
- Wurzel, John F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lower buprenorphine elimination rate constant is associated with lower opioid use
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Expanding access to medications for opioid use disorder through locally-initiated implementation
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Telehealth in opioid use disorder treatment: policy considerations for expanding access to care
Lower buprenorphine elimination rate constant is associated with lower opioid use
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Expanding access to medications for opioid use disorder through locally-initiated implementation
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Telehealth in opioid use disorder treatment: policy considerations for expanding access to care
Lower buprenorphine elimination rate constant is associated with lower opioid use
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Expanding access to medications for opioid use disorder through locally-initiated implementation
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder